Issues: Vax Specific

● Anthrax
● Hepatitis B
● Hib
● HPV
● Influenza
● Lyme Disease
● Meningococcal
● MMR
● Pneumococcal
● Polio
● Rotavirus
● Smallpox
● Tdap/Td
● Varicella
● Yellow Fever

Issues: Misc

● Exemptions
● Legislation
● New Vax Status
● Religion
● Thimerosal

Vaccine Info

● 2017 Schedule
● ACIP Recs
● Components
● IOM Reports
● Vax Injury Comp Prg
● Manufacturer Links
● Package Inserts
● Reporting AEs
● Thimerosal Table
● VAERS
● VISs

Links

Search IVS site

About IVS

● About IVS
● Faculty Biographies
● Publications
● Donations

Email IVS

Disclaimers and Privacy

 

 

Thimerosal Content in Some US Licensed Vaccines

updated 5/2/17

  

Vaccine

Brand Name

Manufacturer

Thimerosal Concentration

Mercury mcg/0.5 mL

Influenza 2016/7 Formula  

Afluria

multi‐dose

CSL Limited for Merck

0.01%

24.5

Afluria Quadrivalent

multi‐dose

CSL Limited for Merck

0.01%

24.5

Agriflu

multi-dose

Novartis

0.01%

25

FluLaval Quadrivalent

multi-dose

GlaxoSmithKline

.01%

25

Fluvirin

prefilled syringe

Novartis

*

*

multi‐dose

0.01%

25

Fluzone Quadrivalent

 multi-dose

sanofi pasteur

0.01%

25

Japanese Encephalitis

JE‐Vax

 

sanofi pasteur

0.007%

 

Meningococcal

Menomune‐A/C/Y/W‐135

multi‐dose

sanofi pasteur

0.01%

24.5

Td

Tetanus and Diphtheria Toxoids Adsorbed

Mass Bio Labs

*

*

* This product should be considered equivalent to thimerosal‐free products. This vaccine may contain trace amounts (<0.3 mcg) of mercury left after postproduction thimerosal removal; these amounts have no biological effect. JAMA 1999;282(18) and JAMA 2000;283(16).

 

This page was last updated on April 5 2017 | 2017 Institute for Vaccine Safety